Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2016 | 10-2015 | 07-2015 | 04-2015 | 01-2015 | |
| Sales | 6,860 | 120 | 0 | 120 | 560 |
| Gross Profit | 6,860 | 120 | N/A | 120 | 560 |
| Operating Expenses | 2,859 | 11,221 | 0 | 1,960 | 3,330 |
| Operating Income | 4,001 | -11,101 | N/A | -1,840 | -2,770 |
| Interest Expense | 0 | 6 | 0 | 0 | 19 |
| Other Income | -31 | -3 | 0 | -10 | 14 |
| Pre-tax Income | 3,970 | -11,110 | 0 | -1,851 | -2,776 |
| Net Income Continuous | 3,970 | -11,110 | N/A | -1,851 | -2,776 |
| Net Income | $3,970 | $-11,110 | $N/A | $-1,851 | $-2,776 |
| EPS Basic Total Ops | 2.11 | -6.00 | N/A | -1.01 | -1.54 |
| EPS Basic Continuous Ops | 2.11 | -6.01 | N/A | -1.01 | -1.54 |
| EPS Diluted Total Ops | 1.52 | -6.00 | N/A | -1.01 | -1.54 |
| EPS Diluted Continuous Ops | 1.52 | -6.01 | N/A | -1.01 | -1.54 |
| EBITDA(a) | $4,002 | $-11,100 | $N/A | $-1,840 | $-2,770 |